Cole Laurence A
USA hCG Reference Service, Obstetrics and Gynecology, and Biochemistry and Molecular Biology, University of New Mexico, Albuquerque, NM, USA.
Reprod Biol Endocrinol. 2009 Jan 26;7:8. doi: 10.1186/1477-7827-7-8.
Human chorionic gonadotropin (hCG) is a glycoprotein hormone comprising 2 subunits, alpha and beta joined non covalently. While similar in structure to luteinizing hormone (LH), hCG exists in multiple hormonal and non-endocrine agents, rather than as a single molecule like LH and the other glycoprotein hormones. These are regular hCG, hyperglycosylated hCG and the free beta-subunit of hyperglycosylated hCG. For 88 years regular hCG has been known as a promoter of corpus luteal progesterone production, even though this function only explains 3 weeks of a full gestations production of regular hCG. Research in recent years has explained the full gestational production by demonstration of critical functions in trophoblast differentiation and in fetal nutrition through myometrial spiral artery angiogenesis. While regular hCG is made by fused villous syncytiotrophoblast cells, extravillous invasive cytotrophoblast cells make the variant hyperglycosylated hCG. This variant is an autocrine factor, acting on extravillous invasive cytotrophoblast cells to initiate and control invasion as occurs at implantation of pregnancy and the establishment of hemochorial placentation, and malignancy as occurs in invasive hydatidiform mole and choriocarcinoma. Hyperglycosylated hCG inhibits apoptosis in extravillous invasive cytotrophoblast cells promoting cell invasion, growth and malignancy. Other non-trophoblastic malignancies retro-differentiate and produce a hyperglycosylated free beta-subunit of hCG (hCG free beta). This has been shown to be an autocrine factor antagonizing apoptosis furthering cancer cell growth and malignancy. New applications have been demonstrated for total hCG measurements and detection of the 3 hCG variants in pregnancy detection, monitoring pregnancy outcome, determining risk for Down syndrome fetus, predicting preeclampsia, detecting pituitary hCG, detecting and managing gestational trophoblastic diseases, diagnosing quiescent gestational trophoblastic disease, diagnosing placental site trophoblastic tumor, managing testicular germ cell malignancies, and monitoring other human malignancies. There are very few molecules with such wide and varying functions as regular hCG and its variants, and very few tests with such a wide spectrum of clinical applications as total hCG.
人绒毛膜促性腺激素(hCG)是一种糖蛋白激素,由α和β两个亚基组成,二者通过非共价键结合。虽然其结构与促黄体生成素(LH)相似,但hCG以多种激素和非内分泌形式存在,而非像LH和其他糖蛋白激素那样以单一分子形式存在。这些形式包括常规hCG、高糖基化hCG以及高糖基化hCG的游离β亚基。88年来,常规hCG一直被认为是黄体孕酮产生的促进剂,尽管这一功能仅能解释整个孕期常规hCG产生的3周情况。近年来的研究通过证明其在滋养层细胞分化以及通过子宫肌层螺旋动脉血管生成实现胎儿营养方面的关键作用,解释了整个孕期的产生情况。常规hCG由融合的绒毛合体滋养层细胞产生,而绒毛外侵袭性细胞滋养层细胞产生变体高糖基化hCG。这种变体是一种自分泌因子,作用于绒毛外侵袭性细胞滋养层细胞,以启动和控制侵袭,如在妊娠着床和血绒毛膜胎盘形成过程中发生的那样,以及在侵袭性葡萄胎和绒毛膜癌中发生的恶性情况。高糖基化hCG抑制绒毛外侵袭性细胞滋养层细胞的凋亡,促进细胞侵袭、生长和恶性转化。其他非滋养层恶性肿瘤会逆向分化并产生hCG的高糖基化游离β亚基(游离β-hCG)。这已被证明是一种自分泌因子,可拮抗凋亡,进一步促进癌细胞生长和恶性转化。在妊娠检测、监测妊娠结局、确定唐氏综合征胎儿风险、预测先兆子痫、检测垂体hCG、检测和管理妊娠滋养层疾病、诊断静止期妊娠滋养层疾病、诊断胎盘部位滋养层肿瘤、管理睾丸生殖细胞恶性肿瘤以及监测其他人类恶性肿瘤方面,已证明总hCG测量和检测3种hCG变体具有新的应用价值。很少有分子具有像常规hCG及其变体这样广泛且多样的功能,也很少有检测方法具有像总hCG这样广泛的临床应用范围。